Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Adrenergic signaling in cardiomyocytes 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
2 Adrenergic signaling in cardiomyocytes 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
3 Calcium signaling pathway 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
4 Calcium signaling pathway 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
5 cAMP signaling pathway 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
6 cAMP signaling pathway 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
7 cGMP-PKG signaling pathway 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
8 cGMP-PKG signaling pathway 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
9 Chemical carcinogenesis - receptor activation 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
10 Chemical carcinogenesis - receptor activation 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
11 Cytokine-cytokine receptor interaction 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
12 Hematopoietic cell lineage 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
13 Hormone signaling 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
14 Hormone signaling 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
15 Inflammatory bowel disease 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
16 JAK-STAT signaling pathway 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
17 Neuroactive ligand signaling 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
18 Neuroactive ligand signaling 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
19 Neuroactive ligand-receptor interaction 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
20 Neuroactive ligand-receptor interaction 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
21 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 Fluticasone 💬 Fluticasone [4] 98, 228, 299, 306 💬
22 Neuroactive ligand-receptor interaction 💬
[1] NR3C1 💬 Fluticasone propionate 💬 Fluticasone propionate [3] 98, 228, 306 💬
23 Pathways in cancer 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
24 PI3K-Akt signaling pathway 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
25 Regulation of lipolysis in adipocytes 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
26 Regulation of lipolysis in adipocytes 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
27 Renin secretion 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
28 Renin secretion 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
29 Salivary secretion 💬
[1] ADRB2 💬 Formoterol fumarate 💬 Formoterol [4] 85, 228, 299, 306 💬
30 Salivary secretion 💬
[1] ADRB2 💬 Formoterol 💬 Formoterol [4] 85, 228, 299, 306 💬
31 Th1 and Th2 cell differentiation 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
32 Th17 cell differentiation 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬